The design and synthesis of 5- and 6-isoxazolylbenzimidazoles as selective inhibitors of the BET bromodomains
Open Access
- 13 August 2012
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 4 (1) , 140-144
Abstract
Simple 1-substituted 5- and 6-isoxazolyl-benzimidazoles have been shown to be potent inhibitors of the BET bromodomains with selectivity over the related bromodomain of CBP.Keywords
This publication has 15 references indexed in Scilit:
- The bromodomain interaction moduleFEBS Letters, 2012
- From ApoA1 upregulation to BET family bromodomain inhibition: Discovery of I-BET151Bioorganic & Medicinal Chemistry Letters, 2012
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain FamilyCell, 2012
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemiaNature, 2011
- Bromodomains as therapeutic targetsExpert Reviews in Molecular Medicine, 2011
- 3,5-Dimethylisoxazoles Act As Acetyl-lysine-mimetic Bromodomain LigandsJournal of Medicinal Chemistry, 2011
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-MycCell, 2011
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemiaNature, 2011
- Suppression of inflammation by a synthetic histone mimicNature, 2010
- Selective inhibition of BET bromodomainsNature, 2010